Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q4 2017 call → NOWe need to determine if management conveys that the business is outgrowing the company's own size, with current activity disproportionately large relative to the company's smallness. Look for statements about current wins, commitments, or volumes that are large relative to the company's revenue or footprint. For example, Bridge revenue growing triple-digit, international revenue 16% of total, Paychex partnership with 0.5 million customers representing 6 million users, etc. Also note that the company is still small (revenue $158M, operating loss). Management mentions that Bridge had triple-digit growth, and that they have over 500 Bridge customers. Also mentions that international revenue reached 16% of total. The Paychex partnership is a significant channel. Also mentions that they have customers in over 65 countries. But does management explicitly convey that what is happening now is disproportionately large relative to the company's size? They talk about strong growth, but not necessarily that the current activity is outgrowing the company's setup. They do mention that they are investing heavily, but that's not the same. They also mention that they expect Bridge to be 15-20% of bookings, which is a significant portion. However, the question asks if management conveys that the business is outgrowing the company's own size. They mention that they are still small and have a large opportunity, but is that specifically about current activity? They mention that they have a large backlog of $387M, which is more than double revenue. That could be seen as large relative to the company. Also, they mention that they have a strong win rate and are winning large deals. But the key is whether management explicitly states that the current business is disproportionately large compared to the company's size. They do say that they are investing in R&D and sales to drive growth, but that's not the same. They also mention that they have a lot of room to grow. However, the question is about the present-tense business, not future potential. They mention that they have a large backlog, which is a commitment. Also, they mention that they have a partnership with Paychex that could bring in many customers. But is that already happening? They say they entered into a partnership, and it's a revenue generating deal with minimums. That is a current commitment.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.